slotkoers
Korea S.E.
00:00:00 03-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3.835
KRW
|
+1,72%
|
|
-0,90%
|
-14,21%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
262.935
|
394.737
|
477.802
|
114.342
|
60.805
|
Bedrijfswaarde
1 |
236.542
|
382.720
|
473.510
|
107.584
|
57.387
|
K/w-verhouding
|
-103
x
|
-95,1
x
|
-36,5
x
|
-5
x
|
-4,15
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
-
|
-
|
525.581.679
x
|
238.211.476
x
|
-
|
Bedrijfswaarde/omzet
|
-
|
-
|
520.860.841
x
|
224.134.002
x
|
-
|
Bedrijfswaarde/EBITDA
|
-69,1
x
|
-79,8
x
|
-44,2
x
|
-8,74
x
|
-6,02
x
|
Bedrijfswaarde/FCF
|
-40,1
x
|
-25,8
x
|
-57,4
x
|
-30,9
x
|
-2,89
x
|
FCF Yield
|
-2,49%
|
-3,88%
|
-1,74%
|
-3,24%
|
-34,6%
|
Price to Book
|
5,12
x
|
8,35
x
|
12,3
x
|
5,1
x
|
1,51
x
|
Aantal aandelen (in duizenden)
|
9.579
|
9.699
|
9.731
|
9.731
|
13.603
|
Referentieprijs
2 |
27.450
|
40.700
|
49.100
|
11.750
|
4.470
|
Datum van publicatie
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
|
-
|
-
|
-
|
909,1
|
480
|
-
|
EBITDA
1 |
-2.298
|
-3.421
|
-4.795
|
-10.723
|
-12.311
|
-9.534
|
Bedrijfsresultaat (EBIT)
1 |
-2.375
|
-3.531
|
-5.287
|
-13.011
|
-14.911
|
-12.198
|
Operationele Marge
|
-
|
-
|
-
|
-1.431,2%
|
-3.106,53%
|
-
|
Resultaat voor belastingen (EBT)
1 |
-11.286
|
-2.494
|
-4.126
|
-13.071
|
-22.865
|
-11.611
|
Nettowinst (verlies)
1 |
-11.286
|
-2.494
|
-4.126
|
-13.071
|
-22.865
|
-11.611
|
Nettomarge
|
-
|
-
|
-
|
-1.437,76%
|
-4.763,45%
|
-
|
WPA
2 |
-1.424
|
-265,7
|
-427,9
|
-1.346
|
-2.350
|
-1.078
|
Free Cash Flow
1 |
-11.116
|
-5.893
|
-14.832
|
-8.255
|
-3.485
|
-19.854
|
FCF-marge
|
-
|
-
|
-
|
-908,07%
|
-726,13%
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
7.885
|
26.394
|
12.017
|
4.292
|
6.757
|
3.418
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-11.116
|
-5.893
|
-14.832
|
-8.255
|
-3.485
|
-19.854
|
ROE (netto-inkomsten/eigen vermogen)
|
-283%
|
-7,69%
|
-8,37%
|
-30,4%
|
-74,7%
|
-36,9%
|
ROA (netto-inkomsten/totale activa)
|
-15,5%
|
-6,61%
|
-6,48%
|
-15,1%
|
-17,9%
|
-13,9%
|
Totale activa
1 |
72.923
|
37.703
|
63.634
|
86.520
|
127.716
|
83.601
|
Nettoactief per aandeel
2 |
1.574
|
5.359
|
4.877
|
3.983
|
2.306
|
2.970
|
Cashflow per aandeel
2 |
103,0
|
175,0
|
358,0
|
535,0
|
848,0
|
981,0
|
Capex
1 |
5.817
|
4.284
|
11.715
|
3.112
|
1.203
|
6.922
|
Capex/omzet
|
-
|
-
|
-
|
342,29%
|
250,61%
|
-
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -14,21% | 37,42 mln. | | -1,43% | 103 mld. | | +8,96% | 101 mld. | | +4,40% | 23,07 mld. | | -12,15% | 22,23 mld. | | -4,36% | 18,05 mld. | | -39,98% | 17,18 mld. | | -10,04% | 16,94 mld. | | +6,79% | 14,07 mld. | | +38,61% | 12,35 mld. |
Biotherapeutische geneesmiddelen
|